Advanced search
Publication Cover
Drug, Healthcare and Patient Safety Volume 4, 2012 - Issue
Submit an article Journal homepage
86
Views
3
CrossRef citations to date
0
Altmetric
Review

Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy

Michael A CilibertoDepartment of Neurology, Washington University School of Medicine, St Louis, MO, USA
,
Judith LZ WeisenbergDepartment of Neurology, Washington University School of Medicine, St Louis, MO, USA
&
Michael WongDepartment of Neurology, Washington University School of Medicine, St Louis, MO, USACorrespondence[email protected]
Pages 81-86 | Published online: 26 Jul 2012

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Slobodan Jankovic & Ivana Ilickovic. (2013) The preclinical discovery and development of ezogabine for the treatment of epilepsy. Expert Opinion on Drug Discovery 8:11, pages 1429-1437.
Read now

Articles from other publishers (2)

Yang-Ming Zhang, Hai-Yan Xu, Hai-Ning Hu, Fu-Yun Tian, Fei Chen, Hua-Nan Liu, Li Zhan, Xiao-Ping Pi, Jie Liu, Zhao-Bing Gao & Fa-Jun Nan. (2021) Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate. Journal of Medicinal Chemistry 64:9, pages 5816-5837.
Crossref
M. Reid Groseclose & Stephen Castellino. (2019) An Investigation into Retigabine (Ezogabine) Associated Dyspigmentation in Rat Eyes by MALDI Imaging Mass Spectrometry. Chemical Research in Toxicology 32:2, pages 294-303.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.